LRRK2 and Parkinson disease: Future work will investigate mechanisms by which the LRRK2 pathway associates with and mediates protein aggregation and GVBs, which may uncover interventions targeting protein aggregation related to LRRK2 activity, both in LRRK2 PD and across tauopathies and synucleinopathies.